602 related articles for article (PubMed ID: 16397128)
1. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.
Gonzalez-Rey E; Chorny A; Fernandez-Martin A; Ganea D; Delgado M
Blood; 2006 May; 107(9):3632-8. PubMed ID: 16397128
[TBL] [Abstract][Full Text] [Related]
2. Generating tolerogenic dendritic cells with neuropeptides.
Delgado M
Hum Immunol; 2009 May; 70(5):300-7. PubMed ID: 19405171
[TBL] [Abstract][Full Text] [Related]
3. The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells.
Delgado M; Gonzalez-Rey E; Ganea D
J Immunol; 2005 Dec; 175(11):7311-24. PubMed ID: 16301637
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.
Chorny A; Gonzalez-Rey E; Fernandez-Martin A; Pozo D; Ganea D; Delgado M
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13562-7. PubMed ID: 16150720
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response.
Chorny A; Gonzalez-Rey E; Fernandez-Martin A; Ganea D; Delgado M
Blood; 2006 May; 107(9):3787-94. PubMed ID: 16418327
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
Gonzalez-Rey E; Delgado M
Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
[TBL] [Abstract][Full Text] [Related]
7. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation.
Chorny A; Gonzalez-Rey E; Delgado M
Ann N Y Acad Sci; 2006 Nov; 1088():187-94. PubMed ID: 17192565
[TBL] [Abstract][Full Text] [Related]
8. Macrophage colony-stimulating factor drives cord blood monocyte differentiation into IL-10(high)IL-12absent dendritic cells with tolerogenic potential.
Li G; Kim YJ; Broxmeyer HE
J Immunol; 2005 Apr; 174(8):4706-17. PubMed ID: 15814695
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis.
Delgado M; Gonzalez-Rey E; Ganea D
Ann N Y Acad Sci; 2006 Jul; 1070():233-8. PubMed ID: 16888172
[TBL] [Abstract][Full Text] [Related]
10. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
11. APVO210: A Bispecific Anti-CD86-IL-10 Fusion Protein (ADAPTIR™) to Induce Antigen-Specific T Regulatory Type 1 Cells.
Pellerin L; Chen P; Gregori S; Hernandez-Hoyos G; Bacchetta R; Roncarolo MG
Front Immunol; 2018; 9():881. PubMed ID: 29887861
[TBL] [Abstract][Full Text] [Related]
12. CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.
Price JD; Beauchamp NM; Rahir G; Zhao Y; Rieger CC; Lau-Kilby AW; Tarbell KV
J Leukoc Biol; 2014 Feb; 95(2):325-36. PubMed ID: 24082013
[TBL] [Abstract][Full Text] [Related]
13. Tolerogenic dendritic cells: cytokine modulation comes of age.
Rutella S; Danese S; Leone G
Blood; 2006 Sep; 108(5):1435-40. PubMed ID: 16684955
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
[TBL] [Abstract][Full Text] [Related]
15. Human Regulatory Dendritic Cells Develop From Monocytes in Response to Signals From Regulatory and Helper T Cells.
Zhang X; Zheng P; Prestwood TR; Zhang H; Carmi Y; Tolentino LL; Wu N; Choi O; Winer DA; Strober S; Kang ES; Alonso MN; Engleman EG
Front Immunol; 2020; 11():1982. PubMed ID: 32973804
[TBL] [Abstract][Full Text] [Related]
16. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.
Robb RJ; Lineburg KE; Kuns RD; Wilson YA; Raffelt NC; Olver SD; Varelias A; Alexander KA; Teal BE; Sparwasser T; Hammerling GJ; Markey KA; Koyama M; Clouston AD; Engwerda CR; Hill GR; MacDonald KP
Blood; 2012 Jun; 119(24):5898-908. PubMed ID: 22538855
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal polypeptide induces regulatory dendritic cells that prevent acute graft versus host disease and leukemia relapse after bone marrow transplantation.
Delgado M; Chorny A; Ganea D; Gonzalez-Rey E
Ann N Y Acad Sci; 2006 Jul; 1070():226-32. PubMed ID: 16888171
[TBL] [Abstract][Full Text] [Related]
18. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.
Torres-Aguilar H; Aguilar-Ruiz SR; González-Pérez G; Munguía R; Bajaña S; Meraz-Ríos MA; Sánchez-Torres C
J Immunol; 2010 Feb; 184(4):1765-75. PubMed ID: 20083662
[TBL] [Abstract][Full Text] [Related]
19. Induction of tolerance by IL-10-treated dendritic cells.
Steinbrink K; Wölfl M; Jonuleit H; Knop J; Enk AH
J Immunol; 1997 Nov; 159(10):4772-80. PubMed ID: 9366401
[TBL] [Abstract][Full Text] [Related]
20. CCL18 differentiates dendritic cells in tolerogenic cells able to prime regulatory T cells in healthy subjects.
Azzaoui I; Yahia SA; Chang Y; Vorng H; Morales O; Fan Y; Delhem N; Ple C; Tonnel AB; Wallaert B; Tsicopoulos A
Blood; 2011 Sep; 118(13):3549-58. PubMed ID: 21803856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
